Bone Marrow Transplantation for Acute Myelogenous Leukemia
Factors Associated With Early Mortality
- Mortimer M. Bortin, MD;
- Robert P. Gale, MD, PhD;
- Humphrey E. M. Kay, FRCPath;
- Alfred A. Rimm, PhD
Abstract
Comprehensive data were reported to the International Bone Marrow Transplant Registry, Milwaukee, regarding 156 patients with acute myelogenous leukemia who were treated with allogeneic bone marrow transplantation between 1978 and 1980. The minimum observation period was 15 months after transplant and most deaths occurred within the first six months. Prognostic factors were evaluated for associations with early mortality or life-threatening complications. Most early deaths were due to infections, interstitial pneumonitis, and graft- v-host disease (GVHD). Multivariate analyses disclosed five factors with significant associations with early death or a major cause of early death: (1) disease status; (2) dose-rate of irradiation; (3) drug used to prevent GVHD; (4) severity of GVHD; and (5) dose of marrow cells. It is emphasized that several of the important prognostic factors are within the control of the referring physician or the transplant team.
(JAMA 1983;249:1166-1175)
Footnotes
-
Reprint requests to International Bone Marrow Transplant Registry, Mount Sinai Medical Center, PO Box 342, Milwaukee, WI 53233 (Dr Bortin).
